Kandzari, DE; Kario, K; Mahfoud, F; Cohen, SA; Pilcher, G; Pocock, S; Townsend, R; Weber, MA; Bohm, M; (2015) The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. American heart journal, 171 (1). pp. 82-91. ISSN 0002-8703 DOI: https://doi.org/10.1016/j.ahi.2015.08.021 Full text not available from this repository.

White, HD; Chew, DP; Hoekstra, JW; Miller, CD; Pollack, CV; Feit, F; Lincoff, AM; Bertrand, M; Pocock, S; Ware, J; +3 more... Ohman, EM; Mehran, R; Stone, GW; (2008) Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy. Journal of the American College of Cardiology, 51 (18). pp. 1734-1741. ISSN 0735-1097 DOI: https://doi.org/10.1016/j.jacc.2007.12.052 Full text not available from this repository.

Stone, GW; White, HD; Ohman, EM; Bertrand, ME; Lincoff, AM; McLaurin, BT; Cox, DA; Pocock, SJ; Ware, JH; Feit, F; +5 more... Colombo, A; Manoukian, SV; Lonsky, AJ; Mehran, R; Moses, JW; (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet, 369 (9565). pp. 907-919. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(07)60450-4 Full text not available from this repository.